A young parolee brings unforeseen magic to a forlorn little town in “The Spitfire Grill,” running at Ross Valley Players through Feb. 23.

In the grimdark future of the 41st millennium, there is only war, and you can fight your way through it, beginning with the ...

Charlotte Wood’s novel, a Booker Prize finalist, follows an atheist whose mysterious path led her to live among nuns in a ...

Frank is a by-the-book sort of fellow, constantly analyzing the situation ... Before they can leave the tiny Nevada town of ...

In the assessment of 12-month price targets, analysts unveil insights for Gilead Sciences, presenting an average target of ...

Gilead Sciences, Inc. (NASDAQ:GILD), a leading biopharmaceutical company with a market capitalization of $119.32 billion, has been making significant strides in its core HIV franchise while expanding ...

JP Morgan highlights mixed sentiment for U.S. large-cap biopharma stocks as advancements in obesity drugs and key product launches shape 2025 outlook. Galapagos NV plans to split into two entities ...

Gilead Sciences reached a settlement with the Justice Department and HHS that resolves a five-year legal dispute regarding patents for its HIV prevention drugs, Truvada and Descovy. The litigation ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Tango Therapeutics is a growing cancer drug development company with partners such as Gilead Sciences. Explore more details ...

View Gilead Sciences, Inc. (GILD) current and estimated P/E ratio data provided by Seeking Alpha.

Don’t we have legislation in place to prevent foreign electoral interference? Because now would be a good time to press that ...